FDA Approves Simponi for Rheumatoid Arthritis
Links shared publicly online about this topic
Rheumatoid Arthritis - Biologic Medications for Rheumatoid Arthritis: Cimzia vs. Simponi
healthcentral.com — “With nine biologic medications available to treat rheumatoid arthritis, it can be difficult knowing which to choose and how they compare. Read my previous...” View full resource at healthcentral.com
Most Recently Shared on May 3, 2010 at 2:34 pm By:
Biologic Medications for RA: Cimzia vs. Simponi - With nine biologic medications available to treat rheumatoid arth... http://ow.ly/17fDbf
Simponi (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
bigtweet.com — “Simponi (golimumab) is used to treat rheumatoid arthritis, active psoriatic arthritis and active ankylosing spondylitis. Includes Simponi side effects, interactions and indications.” View full resource at bigtweet.com
Most Recently Shared on May 15, 2009 at 6:39 pm By:
Spondylitis.org Health Organization
New anti-TNF - Simponi (golimumab) approved for spondylitis by FDA http://bit.ly/g7feq
Simponi Label May Receive Changes for RA Indications
hcplive.com — “Centocor Ortho Biotech Inc. has submitted a supplemental Biologics License Application to the FDA to expand the Simponi (golimumab) physician label.” View full resource at hcplive.com
Most Recently Shared on September 28, 2010 at 4:10 pm By:
#Simponi Label May Receive Changes for #RA Indications http://hcp.lv/dbvdxk
SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
news.prnewswire.com — “SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis” View full resource at news.prnewswire.com
Most Recently Shared on April 24, 2009 at 9:19 pm By:
National Psoriasis Foundation Dermatology and Health Organization
SIMPONI receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Psoriatic Arthritis http://tinyurl.com/dju3pp
FDA Approves New Drug For Rheumatoid Arthritis
medicalnewstoday.com — “The u.s. food and drug administration approved actemra (tocilizumab) on friday to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate ” View full resource at medicalnewstoday.com
Most Recently Shared on January 12, 2010 at 4:08 pm By:
MNT Arthritis News Health News
FDA Approves New Drug For Rheumatoid Arthritis http://mnt.to/3wbv
Centocor Ortho Biotech Inc. Submits Application To FDA Seeking To Expand SIMPONI(R) Label In Treatment Of Rheumatoid Arthritis
medicalnewstoday.com — “Centocor Ortho Biotech Inc. announced today that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking to expand the SIMPONI&r” View full resource at medicalnewstoday.com
Most Recently Shared on September 28, 2010 at 12:05 pm By:
MNT Arthritis News Health News
Centocor Ortho Biotech Inc. Submits Application To FDA Seeking To Expand SIMPONI(R) Label In Treatment Of Rheumatoid A... http://mnt.to/3Kq5
FDA Approves Actemra for Treatment of Rheumatoid Arthritis
emaxhealth.com — “Yesterday, Genetech Inc (a subsidiary of the Roche Group) announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizuma...” View full resource at emaxhealth.com
Most Recently Shared on January 9, 2010 at 7:00 pm By:
Dr. Kevin Smith Doctor, CAM, and Chiropractor
FDA Approves Actemra for Treatment of Rheumatoid Arthritis ...: Yesterday, Genetech Inc (a subsidiary of the Ro.. http://bit.ly/5oOGXA
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 12, 2010 at 12:27 am By:
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis - http://bit.ly/8vWion
FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
drugs.com — “Actemra (tocilizumab) is used to treat Rheumatoid Arthritis and Systemic Juvenile Idiopathic Arthritis . Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 19, 2011 at 3:15 am By:
FDA Approves Actemra for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA) - http://bit.ly/gKMQJR
Medicine and Technology [part of HCPLive]: FDA approves Actemra (tocilizumab) for rheumatoid arthritis
medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: FDA approves Actemra (tocilizumab) for rheumatoid arthritis” View full resource at medicineandtechnology.com
Most Recently Shared on January 12, 2010 at 4:19 am By:
Joseph Kim, MD, MPH Doctor and Physician
FDA approves Actemra (tocilizumab) for rheumatoid arthritis http://bit.ly/5xmlaz
Simponi Information from Drugs.com
drugs.com — “Simponi (golimumab) is used to treat rheumatoid arthritis, active psoriatic arthritis and active ankylosing spondylitis. Includes Simponi side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 30, 2009 at 10:35 pm By:
New Drug Simponi approved for Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis - http://www.drugs.com/simponi.html
New FDA approved drug battles rheumatoid arthritis | KDRV
kdrv.com — “New FDA approved drug battles rheumatoid arthritis | KDRV” View full resource at kdrv.com
Most Recently Shared on September 23, 2010 at 2:33 am By:
New FDA approved drug battles rheumatoid arthritis: RA destroys the cartilage and bone around the joint, and can o... http://bit.ly/ae7AWP
FDA Approves New Drug for Moderate to Severe Rheumatoid Arthritis
seniorjournal.com — “Jan. 12, 2010 - The U.S. Food and Drug Administration has approved Actemra (tocilizumab) to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved drug classes for rheumatoid arthritis. The majority of America's 1.3 million RA patients are senior citizens with the average age for all RA victims being 66.8 years. Alerts for senior citizens and baby boomers.” View full resource at seniorjournal.com
Most Recently Shared on January 22, 2010 at 9:30 pm By:
Steve Jorgenson Health Executive
FDA Approves New Drug for Moderate to Severe Rheumatoid Arthritis http://ow.ly/XRAm
FDA Approves Rheumatoid-Arthritis Drug - WSJ.com
online.wsj.com — “The FDA approved a new type of drug by Roche Holding's Genentech unit to treat rheumatoid arthritis in patients who have failed other treatments.” View full resource at online.wsj.com
Most Recently Shared on January 9, 2010 at 2:41 am By:
FDA Approves Rheumatoid-Arthritis Drug http://bit.ly/5wA28r
Health Canada Approves Centocor Ortho Biotech Inc. and Schering-Plough Corporation's SIMPONI(TM) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis; First World Regulatory Approval for SIMPONI - News, Search Jobs, Events
biospace.com — “Health Canada Approves Centocor Ortho Biotech Inc. and Schering-Plough Corporation's SIMPONI(TM) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis; First World Regulatory Approval for SIMPONI - News, Search Jobs, Events” View full resource at biospace.com
Most Recently Shared on April 14, 2009 at 10:25 pm By:
National Psoriasis Foundation Dermatology and Health Organization
Health Canada Approves Centocor Ortho Biotech Inc. and Schering-Plough Corporation (SGP)'s SIMPONI(TM) for Treat.. http://tinyurl.com/d8dtxm
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
-
Spondylitis.org
Our Mission: To be a leader in the quest to cure ankylosing spondylitis and related diseases, and to empower those affected to live life to the fullest.
-
HCPLive
Your online destination for Pain Management news,events, and resources
Advertisement
